Cellular immunity

DIAGNOSTIC_TEST2 trials

Sponsors

Institute of Health Information and Statistics of the Czech Republic, Zhongnan Hospital

Conditions

COVID-19ImmunotoxicitySARS-CoV-2SARS-CoV-2 InfectionSafety

Unknown Phase

COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

CompletedNCT05096962

Institute of Health Information and Statistics of the Czech RepublicCOVID-19, SARS-CoV-2 Infection

Start: 2021-09-13End: 2022-02-24Updated: 2022-11-28

The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine

Zhongnan HospitalImmunotoxicity, Safety, SARS-CoV-2

Start: 2022-08-13End: 2023-03-01Target: 1000Updated: 2022-10-12